Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Frazier Healthcare Partners

Frazier Healthcare Partners
VC INVESTOR TYPE
Active STATUS
32 PROFESSIONALS
354 INVESTMENTS
49 PORTFOLIO
157 EXITS
Description

Frazier Healthcare Partners is a private equity investment firm that is based in Seattle, Washington. The firm focuses on investing in companies operating in the pharmaceutical, healthcare services, medical products and biotechnology sectors.

Formerly Known As
Frazier Healthcare
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
1991
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Primary Office
  • Two Union Square, 601 Union Street
  • Suite 3200
  • Seattle, WA 98101
  • United States

+1 (206) 000-0000

Frazier Healthcare Partners Investments (354)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
MedData 31-Oct-2019 Buyout/LBO 00000 Enterprise Systems (Healthcare) Generating Revenue 00000 00000
000 000000 000 000 31-Oct-2019 0000000000 Clinics/Outpatient Services Generating Revenue 0000 00000000
0000000 21-Oct-2019 00000 00000 000.00 Biotechnology Clinical Trials - Phase 3 0000000 00000
0000000 000 04-Sep-2019 00000 00000 00000 Drug Discovery Generating Revenue 0000000 00000
000000 00000000000 23-Aug-2019 00000 00000 0000 Therapeutic Devices Stealth 0000 0000000
0000000 0000000000 15-May-2019 00000 00000 00000 Biotechnology Clinical Trials - Phase 3 00000 00000
0000000 0000000000 15-May-2019 00000 000000 Biotechnology Clinical Trials - Phase 3 00000 00000
0000000 23-Apr-2019 00000 00000 0000 Biotechnology Clinical Trials - Phase 3 0000000 00000
ScoutBio 29-Mar-2019 Early Stage VC 0000 Biotechnology Pre-Clinical Trials 00000000 000000 00
Imago BioSciences 21-Mar-2019 Later Stage VC 0000 Biotechnology Clinical Trials - Phase 2 0000000 00000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Frazier Healthcare Partners’s full profile, request a free trial.

Frazier Healthcare Partners Exits (155)

Company Name Exit Date Exit Type Exit Size Status Buyers
Phathom Pharmaceuticals 25-Oct-2019 IPO 00000 Completed
00000 000000000000 18-Jul-2019 000 0000 Completed
0000000000 15-Jul-2019 000000000000000000 Completed
  • 000000
0000000000 0000000 01-May-2019 0000000000 Completed
  • 2 buyers
000000 00000000000 22-Mar-2019 000000000000000000 Completed
  • 00000000 000000000
00000000000 18-Mar-2019 000000000000000000 00000 Completed
  • 00000
0000000 15-Feb-2019 0000000000: 000000 Completed
0.0. 00000 0000 13-Feb-2019 0000000000 Completed
  • 3 buyers
Gritstone Oncology 28-Sep-2018 IPO 00000 Completed
Entasis Therapeutics 26-Sep-2018 IPO 0000 Completed
To view this investor’s complete exits history, request access »

Frazier Healthcare Partners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is reserved for PitchBook Platform accredited users. To explore Frazier Healthcare Partners‘s full profile, request access.

Request full access to PitchBook

Frazier Healthcare Partners Team (103)

Name Title Deals Funds Boards Office Contact
Info
Thomas Hodge JD Senior Advisor Seattle, WA
Steve Bailey Chief Financial Officer & Partner Seattle, WA
James Topper Ph.D Managing General Partner, Life Sciences 00 0 0 Menlo Park, CA
Patrick Heron Managing General Partner, Life Sciences 00 0 0 Menlo Park, CA
Nader Naini Managing Partner 00 0 0 Seattle, WA

39 Former Team Members

You’re viewing 5 of 103 team members. Get the full list »

Frazier Healthcare Partners Co-Investors (141)

Name With Exits Lead Partner
HBM Healthcare Investments 6 0 0
Novo Holdings 0 0 0
Vivo Capital 0 0 0
HBM Partners 0 0 0
OrbiMed 0 0 0
To view this investor’s complete co-investor history, request access »